fda ban semaglutide 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these FDA Warns on Certain Forms

Unlike FDA-approved medications (e.g., Wegovy, Ozempic, Zepbound), compounded alternatives lack agency review for safety, quality, and efficacy

Introduction: Obesity is a global epidemic affecting 2.5 billion people and is recognized as the fourth leading cause of global mortality

Developed images revealed clear excess adiposity and high health-risk (BRI) at baseline with marked improvements, although not to within the healthy BMI (<25kg/m2) and BRI ranges at 72 weeks, observations not evident in the published report

Busy pros craving restorative sleep

With our team of testers and nutrition experts, we have found the best weight loss programs to help with healthy and manageable habits.

Tirzepatide is a dual-action GLP-1 and GIP therapy designed for individuals who benefit from a more advanced formulation aligned with their specific health g...